{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:30:53Z","timestamp":1793493053646,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.acuroe.2026.501993","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T15:42:12Z","timestamp":1779464532000},"page":"501993","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incidence, risk factors and prognostic impact of pyelonephritis in cancer patients with percutaneous nephrostomy for malignant ureteral obstruction"],"prefix":"10.1016","volume":"50","author":[{"given":"M.","family":"Selman Mert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1305-023X","authenticated-orcid":false,"given":"O.","family":"Murat Ipek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuroe.2026.501993_bib0005","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/bju.15237","article-title":"Predictors for failure of endoscopic ureteric stenting in patients with malignant ureteric obstruction: systematic review and meta-analysis","volume":"127","author":"Guachet\u00e1-Bomba","year":"2021","journal-title":"BJU Int."},{"key":"10.1016\/j.acuroe.2026.501993_bib0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.crad.2003.10.021","article-title":"Percutaneous nephrostomy insertion: outcome data from a propspective multi-operator study at a UK training centre","volume":"59","author":"Wah","year":"2004","journal-title":"Clin Radiol."},{"key":"10.1016\/j.acuroe.2026.501993_bib0015","doi-asserted-by":"crossref","first-page":"401","DOI":"10.48083\/AYKF2124","article-title":"Percutaneous nephrostomy versus retrograde ureteral stent for management of malignant ureteral obstruction in adults: a systematic review of the literature","volume":"4","author":"Eshumani","year":"2023","journal-title":"Soc Int Urol J."},{"key":"10.1016\/j.acuroe.2026.501993_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10112354","article-title":"Outcomes related to percutaneous nephrostomies (PCN) in malignancy-associated ureteric obstruction: a systematic review of the literature","volume":"10","author":"New","year":"2021","journal-title":"J Clin Med."},{"key":"10.1016\/j.acuroe.2026.501993_bib0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/end.2020.0469","article-title":"Long-term follow-up of yearly replaced double internal stents for extrinsic malignant ureteral obstruction","volume":"35","author":"Savin","year":"2021","journal-title":"J Endourol."},{"key":"10.1016\/j.acuroe.2026.501993_bib0030","series-title":"Percutaneous nephrostomy: technical aspects and indications. Seminars in interventional radiology","author":"Dagli","year":"2011"},{"key":"10.1016\/j.acuroe.2026.501993_bib0035","doi-asserted-by":"crossref","first-page":"769","DOI":"10.25122\/jml-2021-0352","article-title":"Ureteral stent complications - experience on 50,000 procedures","volume":"14","author":"Geavlete","year":"2021","journal-title":"J Med Life."},{"key":"10.1016\/j.acuroe.2026.501993_bib0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.48083\/AYKF2124","article-title":"Percutaneous nephrostomy versus retrograde ureteral stent for management of malignant ureteral obstruction in adults: a systematic review of the literature","volume":"4","author":"Eshumani","year":"2023","journal-title":"Soc Int Urol J."},{"key":"10.1016\/j.acuroe.2026.501993_bib0045","doi-asserted-by":"crossref","DOI":"10.1136\/spcare-2024-004937","article-title":"High early mortality following percutaneous nephrostomy in metastatic cancer: a national analysis of outcomes","volume":"14","author":"Dosanjh","year":"2024","journal-title":"BMJ Support Palliat Care."},{"key":"10.1016\/j.acuroe.2026.501993_bib0050","doi-asserted-by":"crossref","first-page":"214","DOI":"10.26502\/jcsct.5079157","article-title":"The role of percutaneous nephrostomy for uretric obstruction due to advanced abdominopelvic malignancy: a retrospective analysis","volume":"6","author":"Mansoor","year":"2022","journal-title":"J Cancer Sci Clin Ther."},{"key":"10.1016\/j.acuroe.2026.501993_bib0055","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000033002","article-title":"Evaluation of risk factors, causative pathogens, and treatment in recurrent percutaneous nephrostomy catheter-related urinary tract infections in cancer patients","volume":"102","author":"Mert","year":"2023","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.acuroe.2026.501993_bib0060","series-title":"Percutaneous nephrostomy","author":"Young","year":"2025"},{"key":"10.1016\/j.acuroe.2026.501993_bib0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00345-019-02663-4","article-title":"A systematic review of the clinical significance of nephrostomy urine cultures","volume":"38","author":"Batura","year":"2020","journal-title":"World J Urol."},{"key":"10.1016\/j.acuroe.2026.501993_bib0070","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1191126","article-title":"Alterations of gut microbiome following gastrointestinal surgical procedures and their potential complications","volume":"13","author":"Tsigalou","year":"2023","journal-title":"Front Cell Infect Microbiol."},{"key":"10.1016\/j.acuroe.2026.501993_bib0075","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12103011","article-title":"Intestinal microbiota in colorectal cancer surgery","volume":"12","author":"Koliarakis","year":"2020","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.acuroe.2026.501993_bib0080","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1177\/000313481207801020","article-title":"Risk factors for postoperative urinary tract infection and urinary retention in patients undergoing surgery for colorectal cancer","volume":"78","author":"Kang","year":"2012","journal-title":"Am Surg."},{"key":"10.1016\/j.acuroe.2026.501993_bib0085","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12893-021-01087-5","article-title":"The gut microbiota and colorectal surgery outcomes: facts or hype? A narrative review","volume":"21","author":"Agnes","year":"2021","journal-title":"BMC Surg."},{"key":"10.1016\/j.acuroe.2026.501993_bib0090","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1148\/radiographics.22.5.g02se081005","article-title":"Complications of ureteral stent placement","volume":"22","author":"Dyer","year":"2002","journal-title":"Radiographics."},{"key":"10.1016\/j.acuroe.2026.501993_bib0095","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s40168-019-0674-x","article-title":"Encrustations on ureteral stents from patients without urinary tract infection reveal distinct urotypes and a low bacterial load","volume":"7","author":"Buhmann","year":"2019","journal-title":"Microbiome."},{"key":"10.1016\/j.acuroe.2026.501993_bib0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/a-1905-4460","article-title":"Ureteral stent colonization and urinary tract infection in children undergoing minimally invasive pyeloplasty","volume":"33","author":"Neheman","year":"2023","journal-title":"Eur J Pediatr Surg."},{"key":"10.1016\/j.acuroe.2026.501993_bib0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2020.100094","article-title":"Ureteral stent microbiota is associated with patient comorbidities but not antibiotic exposure","volume":"1","author":"Al","year":"2020","journal-title":"Cell Reports Medicine"},{"key":"10.1016\/j.acuroe.2026.501993_bib0110","doi-asserted-by":"crossref","first-page":"61","DOI":"10.14777\/uti.2021.16.3.61","article-title":"Ureteral stent induced urinary tract infection and microbial inconsistency between bladder and renal pelvis","volume":"16","author":"Choi","year":"2021","journal-title":"Urogenital Tract Infection."},{"key":"10.1016\/j.acuroe.2026.501993_bib0115","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s11912-002-0023-1","article-title":"The role of C-reactive protein as a prognostic indicator in advanced cancer","volume":"4","author":"Mahmoud","year":"2002","journal-title":"Curr Oncol Rep."},{"key":"10.1016\/j.acuroe.2026.501993_bib0120","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11051207","article-title":"Serum hypoalbuminemia is a long-term prognostic marker in medical hospitalized patients, irrespective of the underlying disease","volume":"11","author":"Oster","year":"2022","journal-title":"J Clin Med."},{"key":"10.1016\/j.acuroe.2026.501993_bib0125","doi-asserted-by":"crossref","first-page":"R291","DOI":"10.1186\/cc2893","article-title":"Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care","volume":"8","author":"Williams","year":"2004","journal-title":"Crit Care."},{"key":"10.1016\/j.acuroe.2026.501993_bib0130","article-title":"Association of cancers with the occurrence and 28-day mortality of sepsis: a mendelian randomization and mediator analysis","volume":"15","author":"Cheng","year":"2025","journal-title":"Sci Rep."},{"key":"10.1016\/j.acuroe.2026.501993_bib0135","doi-asserted-by":"crossref","DOI":"10.3390\/life11121387","article-title":"Risk factors for infections, antibiotic therapy, and its impact on cancer therapy outcomes for patients with solid tumors","volume":"11","author":"Kube\u010dek","year":"2021","journal-title":"Life."},{"key":"10.1016\/j.acuroe.2026.501993_bib0140","first-page":"56","article-title":"Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options","volume":"9","author":"Liu","year":"2022","journal-title":"Mil Med Res."},{"key":"10.1016\/j.acuroe.2026.501993_bib0145","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s10120-020-01102-3","article-title":"Impact of postoperative complications on survival outcomes in patients with gastric cancer: exploratory analysis of a randomized controlled JCOG1001 trial","volume":"24","author":"Tokunaga","year":"2021","journal-title":"Gastric Cancer."}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578626001010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578626001010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:19:56Z","timestamp":1793492396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173578626001010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2173578626001010"],"URL":"https:\/\/doi.org\/10.1016\/j.acuroe.2026.501993","relation":{},"ISSN":["2173-5786"],"issn-type":[{"value":"2173-5786","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence, risk factors and prognostic impact of pyelonephritis in cancer patients with percutaneous nephrostomy for malignant ureteral obstruction","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuroe.2026.501993","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2026.501993","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AEU. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"501993"}}